Prospects for the use of differentiation‐modulating agents as adjuvant of photodynamic therapy for proliferative dermatoses

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of dermatology (Print)

• Publication date

  2008-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1346-8138.2008.00445.xPMID 18419676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Photodynamic therapy for actinic keratoses.

  2007cited by this paper
• Protoporphyrin biosynthesis in Melanoma B16 cells stimulated by 5‐aminolevulinic acid and chemical inducers: Characterization of photodynamic inactivation

  2007cited by this paper
• Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

  2007cited by this paper
• Vitamin D enhances ALA-induced protoporphyrin IX production and photodynamic cell death in 3-D organotypic cultures of keratinocytes.

  2007cited by this paper
• A mechanistic study of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis.

  2007cited by this paper
• Parasiticidal effect of δ‐aminolevulinic acid‐based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells

  2007cited by this paper
• Methyl aminolaevulinate–photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer

  2007cited by this paper
• Topical 5‐aminolaevulinic acid photodynamic therapy for intractable palmoplantar psoriasis

  2007cited by this paper
• Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.

  2007cited by this paper
• Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation

  2007cited by this paper
• Pathogenesis and therapy of psoriasis

  2007cited by this paper
• Nuclear transcription factors: a new approach to enhancing cellular responses to ALA-mediated photodynamic therapy

  2006cited by this paper
• Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells

  2006cited by this paper
• Photodynamic therapy against intracellular pathogens: Problems and potentials

  2006cited by this paper
• Heterogeneity of fluorescence in psoriasis after application of 5‐aminolaevulinic acid: an immunohistochemical study

  2006cited by this paper
• Targeting of Sebocytes by Aminolevulinic Acid-dependent Photosensitization

  2006cited by this paper
• International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors

  2006cited by this paper
• Transcriptional modulation of coproporphyrinogen oxidase by CCAAT enhancer binding proteins (C/EBPs) and their isoforms: A possible mechanism for enhanced ALA-photodynamic therapy

  2006cited by this paper
• Disappointing results and low tolerability of photodynamic therapy with topical 5‐aminolaevulinic acid in psoriasis. A randomized, double‐blind phase I/II study

  2006cited by this paper
• A placebo‐controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5‐aminolaevulinic acid‐photodynamic therapy in patients with psoriasis

  2006cited by this paper
• Griseofulvin Enhances the Effect of Aminolevulinic Acid–Based Photodynamic Therapy in Vitro

  2006cited by this paper
• Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5‐aminolaevulinic acid photodynamic therapy

  2005cited by this paper
• The potential for photodynamic therapy in the treatment of localized infections.

  2005cited by this paper
• Photodynamic therapy in dermatology – an update

  2005cited by this paper
• Topical aminolaevulinic acid‐based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer‐blinded study

  2005cited by this paper
• Recalcitrant palmoplantar pustular psoriasis successfully treated with topical 5‐aminolaevulinic acid photodynamic therapy

  2005cited by this paper
• A Review of Laser and Photodynamic Therapy for the Treatment of Nonmelanoma Skin Cancer

  2004cited by this paper
• Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapy

  2004cited by this paper
• Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo

  2004cited by this paper
• Methyl aminolevulinate (Metvix®) photodynamic therapy - practical pearls

  2003cited by this paper
• Role of cytokines in photodynamic therapy-induced local and systemic inflammation

  2003cited by this paper
• Photodynamic therapy for nonmelanoma skin cancers. Current review and update.

  2003cited by this paper
• Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group

  2002cited by this paper
• Non-oncologic indications for ALA-PDT

  2002cited by this paper
• Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells

  2002cited by this paper
• Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques.

  2002cited by this paper
• 5-Aminolaevulinic acid-mediated photodynamic therapy in multidrug resistant leukemia cells.

  2001cited by this paper
• Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma.

  2001cited by this paper
• Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial.

  2000cited by this paper
• Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5‐aminolaevulinic acid: a pilot study

  1999cited by this paper
• Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation.

  1999cited by this paper
• Photodynamic therapy of recalcitrant warts with 5-aminolevulinic acid: a retrospective analysis.

  1999cited by this paper
• Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes.

  1998cited by this paper
• Potent differentiation-inducing properties of the antiretroviral agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in the rat choriocarcinoma (RCHO) tumor cell model.

  1998cited by this paper
• Treatment of viral infections with 5‐aminolevulinic acid and light

  1997cited by this paper
• Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin.

  1997cited by this paper
• Treatment of recalcitrant verrucae by photodynamic therapy with topical application of δ‐aminolaevulinic acid

  1996cited by this paper
• Topical photodynamic therapy in verrucae. A pilot study.

  1995cited by this paper
• The nuclear hormone receptor gene superfamily.

  1995cited by this paper
• Retinoic acid and methotrexate specifically increase PHA‐E‐lectin binding to a 67‐kDa glycoprotein in LA‐N‐1 human neuroblastoma cells

  1995cited by this paper
• Keratinocytes differentiate in response to inhibitors of deoxyribonucleotide synthesis.

  1995cited by this paper
• Coproporphyrinogen oxidase. Purification, molecular cloning, and induction of mRNA during erythroid differentiation.

  1993cited by this paper
• Methotrexate induces differentiation of human keratinocytes.

  1992cited by this paper
• Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light.

  1991cited by this paper
• 1,25-Dihydroxyvitamin D3 stimulates specifically the last steps of epidermal differentiation of cultured human keratinocytes.

  1991cited by this paper
• Cytotoxic and immunologic effects of methotrexate in psoriasis.

  1990cited by this paper
• Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.

  1990cited by this paper
• Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages.

  1990cited by this paper
• [Photodynamic therapy of psoriasis palmaris et plantaris using a topically applied hematoporphyrin derivative and visible light].

  1989cited by this paper
• Photodynamic Therapy for Nonmelanoma Skin Cancer

  1989cited by this paper
• Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate.

  1981cited by this paper
• Morphological differentiation of human choriocarcinoma cells induced by methotrexate.

  1979cited by this paper

• Adjuvants that Empower the Action of Photodynamic Therapy

  2020cites this paper
• Assessing daylight & low-dose rate photodynamic therapy efficacy, using biomarkers of photophysical, biochemical and biological damage metrics in situ.

  2017cites this paper
• Chlorin E6 phototoxicity in L. major and L. braziliensis promastigotes-In vitro study.

  2016cites this paper
• Revisiting photodynamic therapy dosimetry: reductionist & surrogate approaches to facilitate clinical success

  2016cites this paper
• Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.

  2015cites this paper
• White light-informed optical properties improve ultrasound-guided fluorescence tomography of photoactive protoporphyrin IX

  2013cites this paper
• Subsurface PpIX imaging in vivo with ultrasound-guided tomographic spectroscopy: reconstruction vs. born-normalized data

  2013cites this paper
• Vitamin D Combined with Aminolevulinate (ALA)-Mediated Photodynamic Therapy (PDT) for Human Psoriasis: A Proof-of-Principle Study.

  2012cites this paper
• The Vitamin D Analog Calcipotriol Combined with Aminolevulinate-Mediated Photodynamic Therapy for Human Psoriasis: A Proof-of-Principle Study

  2012cites this paper
• Assessment of Leishmania major and Leishmania braziliensis promastigote viability after photodynamic treatment with aluminum phthalocyanine tetrasulfonate (AlPcS4)

  2011cites this paper
• Targeting of sebaceous glands by δ‐aminolevulinic acid‐based photodynamic therapy: An in vivo study

  2011cites this paper
• Vitamin D as a potential enhancer of aminolevulinate-based photodynamic therapy for nonmelanoma skin cancer

  2010cites this paper
• Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP

  2010cites this paper
• Enhancement and optimization of PpIX-based photodynamic therapy of skin cancer: translational studies from bench to clinic

  2009cites this paper
• Optimization of topical photodynamic therapy with 3,7‐bis(di‐n‐butylamino)phenothiazin‐5‐ium bromide for cutaneous leishmaniasis

  2009cites this paper